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 ABSTRACT 
 
Objective: To investigate the effect of low dose amlodipine v/s nifedipine on serum cholesterol profile of 
rabbits receiving standard diet. Methods: Fourty Newzealand rabbits were selected for the study. Their 
cholesterol  profile  was  estimated  at  the  beginning  of  the  study.  Rabbits  were  grouped  into  4  groups 
receiving standard diet (control group), standard diet + vehicle propylene glycol, standard diet + nifedipine 
dissolved in propylene glycol and standard diet + amlodipine dissolved in propylene glycol. Along with 
standard  diet  they  were  treated  with  respective  drugs  for  ten  weeks.  At  the  end  of  ten  weeks  serum 
cholesterol profile was estimated. Results: The cholesterol profile was estimated at the beginning and at the 
end of ten weeks. Total cholesterol in the amlodipine group decreased from 97±4.06 mg/dl to 90±4.2 mg/dl 
and HDL-Cholesterol increased from 32.01±4.40 mg/dl to 37±4.60 mg/dl after 10 week treatment but these 
changes  were  not  significant.  LDL  cholesterol  decreased  significantly  in  rabbits  with  low  dose  of 
amlodipine from 55.42±3.32 mg/dl to 32.40±3.22 mg/dl and. In the nifedipine group there was a slight 
increase in total cholesterol from 102.49±5.16 mg/dl to 106±5.39 mg/dl, HDL cholesterol from 34.10±2.80 
to 35.16±2.82 mg/dl and LDL cholesterol also increased from 56.20±2.20 mg/dl to 59.00±2.20 mg/dl after 
10 week treatment.   Conclusion:  The  study shows amlodipine produces favorable alterations in  serum 
cholesterol profile. 
 
Key words: Cholesterol profile, Standard diet, Amlodipine, Nifedipine   
 
INTRODUCTION 
 
Hyperlipidaemia  and  hypertension  are  often  two 
co-existing risk factors for coronary artery disease. 
Among different cholesterol high serum levels of 
total  cholesterol  and  low  density  lipoprotein 
cholesterol  favours  coronary  artery  disease.  A 
report  by  the  National  cholesterol  education 
program
11 has  focused  attention on  the necessity 
for  managing  lipid  disorders.
  Serum  cholesterol 
plays a central role in the atherosclerotic process, 
in particular, abnormal  levels of total cholesterol 
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and  low  –  density  lipoprotein  cholesterol.  High 
density  lipoprotein  particles  function  in  the 
opposite  way  from  low  density  lipoprotein,  they 
act as a scavenger of free cholesterol and enhance 
the  rate  of  clearance  of  cholesterol  from  the 
arteries.
3 It has been reported in a large number of 
animal  and  human  experimental  studies  that 
various  classes  of  antihypertensive  agents  have 
either adverse or significant, effect on plasma lipid 
&  lipoprotein  levels.
1,4,5  Beta-blockers  without 
partial intrinsic sympathomimetic activity increase 
serum triglycerides and tend to lower high-density 
lipoprotein cholesterol.
9 Recently there has been an 
epidemical increase in hypertensive cases resulting 
in  coronary  artery  disease  and  abnormal  lipid 
profile. Therefore we planned in this study to see 
whether amlodipine versus nifedipine to test if this 
drug having antihypertensive effect in human, has 
any effect on serum cholesterol profile of rabbits 
fed on standard diet.  
 
 
MATERIALS AND METHOD 
 
Fourty healthy male Newzealand rabbits weighing 
between  2-3  Kg  was  selected  and  placed  under 
ideal conditions. Animals were maintained on the 
routine  standard  feed  and acclimatized  for  seven 
days  prior  to  start  of  the  experiment.  Nifedipine 
(Pfizer Ltd): A solution of 5 mg/40ml in propylene 
glycol prepared and administered orally in a dose 
of  2ml/kg  i.e.  0.25  mg/kg  orally.  Amlodipine 
(Pfizer  Ltd):  A  solution  of  2.5mg/40  ml  in 
propylene glycol prepared and administered orally 
in  a  dose  of  2ml/kg  i.e.  0.125  mg/kg  orally. 
Estimations of serum total cholesterol and serum 
high and low density lipoprotein cholesterol were 
done  at  the  beginning  of  the  study  and  after  10 
weeks of administration of the study drugs.   
Study design  
The  rabbits  were  divided  into  four  groups 
containing  10  rabbits  each.    The  groups  were 
treated as follows:  
Group I Standard diet (control group) 
Group II Standard diet+ vehicle propylene glycol 
2ml/kg/day  
Group III Standard diet +Nifedipine 
(0.25mg/kg/day) 
Group IV Standard diet +Amlodipine 
0.125mg/kg/day orally 
A routine diet containing bread, milk and vegetable 
on  an  average of 100gm/rabbit was  given to  the 
rabbits during the study  period with  water given 
ad-libitum.    The  animals  were  treated  in  this 
manner for 10 weeks.  For analysis of cholesterol 
profile i.e.  total cholesterol, HDL-cholesterol and 
LDL-cholesterol 1ml blood samples were collected 
from  the  marginal  ear  vein  of    rabbit  after  an 
overnight fast at  the   beginning before starting the 
drug administration and then after ten weeks of the 
drug  administration.    Readings  were  taken  on  a 
photo colorimeter. The data were analyzed using 
students  paired  ‘t’  test  for  the  same  group  and 
students unpaired t test for between the groups.  
 
Table: 1. Cholesterol profile in the rabbits baseline values (Pretreatment)                    
 
Sr.
No 
Group   Total Cholesterol (mg/dl)  HDL-cholesterol (mg/dl)  LDL-cholesterol (mg/dl) 
1.  Group I  95.00± 1.28  32.16± 2.08  56.55±3.72 
2.  Group II  97.00± 1.28  34.01± 3.20  54.20± 5.20 
3.  Group III  102.49± 5.16  34.10± 2.80  56.20± 2.20 
4.  Group IV  97.00± 4.06  32.01± 4.40  55.42± 3.32* 
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Table: 2. Cholesterol profile in rabbits after 10 weeks of drug administration  
Sr.
No 
Group   Total Cholesterol (mg/dl)  HDL-cholesterol (mg/dl)  LDL-cholesterol (mg/dl) 
1.  Group I  99.00± 1.28  31.02± 2.08  53.12± 3.72 
2.  Group II  100.00± 1.28  34.00± 3.20  55.00± 5.20 
3.  Group III  106.00± 5.19  35.16± 2.82  59.00± 2.20 
4.  Group IV  90.00± 4.06  37.00± 460.  32.40± 3.32* 
The data were analyzed by paired  ‘t’ test (p<0.001)*LDL-C is decreased significantly  in  group 4 treated with 
amlodipine as compared to group 3 treated with nifedipine , control group1; 2 & pretreatment groups1, 2, 3 & 4. 
 
RESULTS 
 
The group 1 and 2 did not exhibit any significant 
alteration in serum cholesterol profile. There was a 
slight  decrease  in  serum  total  cholesterol  in  the 
group-4 treated with amlodipine than non treated 
group  1,  2  &  4.  But  the  mean  serum  total  and 
LDL-C  levels  of  the  group  4  treated  with 
amlodiine, rabbits were significantly reduced when 
compared  to  group  3  at  tenth  weeks.Thus 
amlodipine  significantly  prevented  the  rise  of 
LDL-C(p<o.oo1). There was a considerable rise in 
HDL-C  in  group 4  rabbits  receiving  amlodipine. 
The mean  serum levels  of HDL-C  of group 3 & 4 
rabbits    receiving    nifedipine  &  amlodipine 
respectively increased marginally after  10 weeks  
than  basal groups. 
 
DISCUSSION  
 
Administration of amlodipine   in group 4 resulted  
in significant lowering  of LDL-C  after 10  weeks  
when  compared    to  group  3  rabbits  receiving  
nifedipine.  Similar  effects  of  nicardipine  in 
lowering  LDL-C and  elevating HDL-C has been 
reported  by  Ohata  et  al
12.    It  is  now  well 
recognized  that  coronary  artery  disease  bears  a 
relationship  through  inter  linkage  between 
hypertension and dyslipidemia.  The treatment of 
hypertension  is  found  with  potential  difficulties, 
including the altered efficiency of medications, the 
increased  risk  of  side  effects  and  possibility  for 
derangement  of  serum  lipid  levels.    Serum 
cholesterol  plays  a  central  role  in  the 
atherosclerotic process, in particular, abnormal  
 
levels of total cholesterol, low density lipoprotein 
cholesterol and high density lipoprotein cholesterol 
have been found to be predictors of coronary heart 
disease risk in hypertension. As the major transport 
vehicles  for  cholesterol,  low-density  lipoprotein 
particles  essentially  deposit  cholesterol  in  the 
lining of the arterial wall; low-density lipoprotein 
cholesterol is often referred to as bad cholesterol.  
High-density lipoprotein particles function in  the 
opposite way from low-density lipoprotein.  They 
act as a scavenger of free cholesterol and enhance 
the  rate  of  clearance  of  cholesterol  from  the 
arteries. Serum high-density lipoprotein cholesterol 
levels  and  subsequent  development  of  coronary 
artery disease in hypertension were also found to 
be related, but in hypertension through the effects 
of diet on plasma lipids.
13 The inverse proportion 
of  the  Framingham  study.
2  Dietary  factors  and 
clinical events of coronary artery disease are linked 
together with high  For these reasons, high density 
lipoprotein cholesterol is often referred to as good 
cholesterol.    Henry  P.D  in  1981
8  showed  that 
calcium  channel  blockers  like  nifedipine  and 
nicardipine  reduce  atherosclerotic  lesions  in 
cholesterol  fed  rabbits  without  any  significant 
effect  on  serum  lipids.It  has  been  reported  that 
calcium channel blockers including nifedipine do 
not  adversely  affect  lipid  profile
7,14  Showed  the 
beneficial effect of low dose felodipine on serum 
cholesterol of rabbits fed on atherogenic diet.   The 
cholesterol  reducing  effect  of  felodipine,  when 
administered  early  has  not  been  explained  
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satisfactorily.  Increased uptake and degradation of 
low density lipoprotein by skin fibroblasts, aortic 
endothelial cells, smooth muscle cell, induction of 
denovo synthesis of apoproteins and inhibition of 
cholesterol synthesis and reduction of cholesterol 
ester  accumulation  in  smooth  muscle  cells  are 
thought  to  be  the  possible  mechanisms.    Many 
studies have demonstrated that arterial compliance 
is improved by antihypertensive drugs that induce 
vasodilation  in  the  large  peripheral  arteries,  e.g. 
calcium  antagonists,  angiotension  converting 
enzyme inhibitors and certain beta adrenoreceptor 
blockers.    Amlodipine  increased  arterial 
compliance  and  dilated  the  brachial  artery  at 
prevailing  and  isobaric  pressure.    The  active 
increase  in  arterial  compliance  with  amlodipine 
was  26%  of  pretreatment  values,  while  passive 
pressure dependent  was  only  14%.
10  It  has  been 
shown experimentally that a reduced response of 
the  arterial  smooth  muscle  to  endothelial 
vasodilators  and  an  increased  sensitivity  to 
vasoconstrictor  agents  may  be  involved  in  the 
abnormal  arterial  reactivity  seem  in 
hypercholesterolemia. The presence of calcium and 
its  role  in  plaque  formation  is  not  yet  fully 
elucidated.
6  Over  the  past  decade,  investigators 
have  demonstrated  that  CCB  like  agents  may 
retard plaque formation.  Recent studies in patients 
with  coronary  artery  disease  have  demonstrated 
that  nifedipine  may  impede  or  prevent  the 
development of atherosclerosis plaques in humans 
as well.
15 
 
CONCLUSION 
 
The present study shows that amlodipine plays a 
favourable  role  in  the  alteration  of  serum 
cholesterol  profile.  Further  studies  confirming 
these findings may open up new avenues for this 
novel group of drugs and pave way for their use in 
many  appropriate  situations  for  prevention  of 
hypercholesterolemia. 
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